Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Ann Thorac Surg. 2019 Dec 23;110(2):500–507. doi: 10.1016/j.athoracsur.2019.10.085

Table 3.

Postoperative Outcomes

Variables Stentless Valve Replacement Age p-value*
<40 40–59 60–74 ≥75
(n=1947) (n=105) (n=528) (n=860) (n=454)
Hours to Extubation 11 (5, 18) 1 (1, 380) 241 (1, 542) 291 (11, 571) 314 (112, 601) <0.001
Reoperation for Bleeding/Tamponade 77 (4.0) 5 (4.8) 18 (3.4) 31 (3.6) 23 (5.1) 0.503
MI 8 (0.4) 0 (0) 1 (0.2) 2 (0.2) 5 (1.1) 0.13
CVA 40 (2.0) 0 (0) 5 (0.9) 20 (2.3) 15 (3.3) 0.026
Atrial Fibrillation 718 (37) 10 (9.5) 150 (28) 340 (40) 218 (48) <0.001
CHB or Pacemaker 81 (4.2) 6 (5.7) 19 (3.6) 35 (4.1) 21 (4.6) 0.725
Post-op Creatinine (mg/dL) 1.1 (0.9, 1.4) 1 (0.8, 1.1) 1 (0.9, 1.2) 1.1 (0.9, 1.4) 1.2 (1.0, 1.5) <0.001
New Onset Renal Failure 64 (3.3) 5 (4.8) 20 (3.8) 51 (5.9) 18 (4.0) 0.235
30-day Mortality 51 (2.6) 1 (1) 7 (1.3) 23 (2.7) 19 (4.2) 0.028
Operative Mortality 65 (3.3) 3 (2.9) 11 (2.1) 31 (3.6) 20 (4.4) 0.217

Data presented as n (%) for categorical data. P-value <0.05 defined as statistically significant difference between the four age groups.

Abbreviations: CHB, complete heart block; CVA, cerebral vascular accident; MI, myocardial infarction. We used standard STS definition for all complications. Operative Mortality defined as death in hospital or death within 30 days after procedure.

*:

After Bonferroni correction, p<0.005 was considered significant.